» Articles » PMID: 28900442

Impact of Preoperative Three-Dimensional Computed Tomography Cholangiography on Postoperative Resection Margin Status in Patients Operated Due to Hilar Cholangiocarcinoma

Overview
Publisher Wiley
Specialty Gastroenterology
Date 2017 Sep 14
PMID 28900442
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The purpose of this study was to analyse the value of 3-dimensional computed tomography cholangiography (3D-ERC) compared to conventional retrograde cholangiography in the preoperative diagnosis of hilar cholangiocarcinoma (HC) with special regard to the resection margin status (R0/R1).

Patients And Methods: All hepatic resections performed between January 2011 and November 2013 in patients with HC at the Department of General, Visceral and Transplant Surgery of the RWTH Aachen University Hospital were analysed. All patients underwent an ERC and contrast-enhanced multiphase CT scan or a 3D-ERC.

Results: The patient collective was divided into two groups (group ERC: = 17 and group 3D-ERC: = 16). There were no statistically significant differences between the two groups with regard to patient characteristics or intraoperative data. Curative liver resection with R0 status was reached in 88% of patients in group ERC and 87% of patients in group 3D-ERC ( = 1.00). We could not observe any differences with regard to postoperative complications, hospital stay, and mortality rate between both groups.

Conclusion: Based on our findings, preoperative imaging with 3D-ERC has no benefit for operative planning and R0 resection status. It cannot replace the exploration by an experienced surgeon in a centre for hepatobiliary surgery.

Citing Articles

Methods and Applications of 3D Patient-Specific Virtual Reconstructions in Surgery.

Fletcher J Adv Exp Med Biol. 2022; 1356:53-71.

PMID: 35146617 DOI: 10.1007/978-3-030-87779-8_3.

References
1.
Bartsch F, Heinrich S, Lang H . Limits of Surgical Resection for Bile Duct Cancer. Viszeralmedizin. 2015; 31(3):189-93. PMC: 4569207. DOI: 10.1159/000433482. View

2.
Zaydfudim V, Rosen C, Nagorney D . Hilar cholangiocarcinoma. Surg Oncol Clin N Am. 2014; 23(2):247-63. DOI: 10.1016/j.soc.2013.10.005. View

3.
Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N . Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol. 2010; 18(3):651-8. DOI: 10.1245/s10434-010-1325-4. View

4.
Rahbari N, Garden O, Padbury R, Brooke-Smith M, Crawford M, Adam R . Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011; 149(5):713-24. DOI: 10.1016/j.surg.2010.10.001. View

5.
DeOliveira M, Cunningham S, Cameron J, Kamangar F, Winter J, Lillemoe K . Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007; 245(5):755-62. PMC: 1877058. DOI: 10.1097/01.sla.0000251366.62632.d3. View